Live Breaking News & Updates on 1st Covid Vaccine In India
Stay updated with breaking news from 1st covid vaccine in india. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Covishield: Manufacturer, dose schedule, efficacy rate, possible side effects and price India Updated: Saturday, January 16, 2021, 15:26 [IST] New Delhi, Jan 16: Covishield vaccine has been developed by the University of Oxford and British-Swedish pharmaceutical company AstraZeneca. Adar Poonawalla, Chief Executive Officer, Serum Institute of India (SII) which is British-Swedish pharma giant AstraZeneca s manufacturing partner - said that the vaccine would be 90 to 95 per cent effective if the two shots are parted by around 2-3 months. File Photo The vaccine is being touted as one of the most promising vaccines for India where cost and logistics play a big roll. You ll be hearing some good news from the UK very soon. It would be a 90-95 per cent effective vaccine if you just keep a two-to-three months gap between dose 1 and dose 2. They will make that public with documentation. ....
What does the consent form that must be signed by Covaxin recipients say? India Published: Saturday, January 16, 2021, 15:29 [IST] New Delhi, Jan 16: The consent form that must be signed by Covaxin beneficiaries states that its efficacy is yet to be established. It assures compensation by Bharat Biotech in case of a serious adverse event that is proven to be causally related to the vaccine. It further states that beneficiaries would be provided care in government-designated facilities if they suffer any adverse events. The form read that only phase 1 and 2 trials have been completed, and that phase 3 is still on. Representational Image ....